Chang AEB, Piper-Vallillo AJ, Mak RH, Lanuti M, et al. The ASCENT Trial: a phase 2 study of induction and consolidation afatinib and chemoradiation with or without surgery in stage III EGFR-mutant NSCLC. Oncologist 2024;29:609-618.
PMID: 38761385